These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28087879)

  • 21. Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial.
    Henry RR; Strange P; Zhou R; Pettus J; Shi L; Zhuplatov SB; Mansfield T; Klein D; Katz A
    Diabetes Technol Ther; 2018 Nov; 20(11):715-724. PubMed ID: 30222367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study.
    Del Olmo-García MI; Hervás Marín D; Caudet Esteban J; Ballesteros Martin-Portugués A; Cerveró Rubio A; Arnau Vives MA; Catalá Gregori A; Penalba Martínez M; Merino-Torres JF
    J Int Med Res; 2020 Jun; 48(6):300060520926063. PubMed ID: 32567433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of glycemic control.
    Shahady EJ
    J Fam Pract; 2011 Sep; 60(9 Suppl):S4-6. PubMed ID: 21912776
    [No Abstract]   [Full Text] [Related]  

  • 24. Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications.
    Huri HZ; Lim LP; Lim SK
    Drug Des Devel Ther; 2015; 9():4355-71. PubMed ID: 26300627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.
    Rodbard HW; Jellinger PS; Davidson JA; Einhorn D; Garber AJ; Grunberger G; Handelsman Y; Horton ES; Lebovitz H; Levy P; Moghissi ES; Schwartz SS
    Endocr Pract; 2009; 15(6):540-59. PubMed ID: 19858063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control.
    Chrvala CA; Sherr D; Lipman RD
    Patient Educ Couns; 2016 Jun; 99(6):926-43. PubMed ID: 26658704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A brief adherence intervention that improved glycemic control: mediation by patterns of adherence.
    de Vries McClintock HF; Morales KH; Small DS; Bogner HR
    J Behav Med; 2015 Feb; 38(1):39-47. PubMed ID: 24913600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in Type 2 Diabetes: Focus on Basal Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy.
    Shubrook JH
    J Fam Pract; 2018 Aug; 67(8 suppl):S49-S54. PubMed ID: 30137054
    [No Abstract]   [Full Text] [Related]  

  • 29. Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
    Morello CM; Nguyen T; Tao L; Hirsch JD
    Ann Pharmacother; 2020 Sep; 54(9):858-865. PubMed ID: 32100551
    [No Abstract]   [Full Text] [Related]  

  • 30. Glycemic control in type 2 diabetes mellitus.
    Quevedo SF; Westrick E
    Med Health R I; 1998 Nov; 81(11):345-8. PubMed ID: 15580787
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.
    Rama Chandran S; A Vigersky R; Thomas A; Lim LL; Ratnasingam J; Tan A; S L Gardner D
    Diabetes Technol Ther; 2020 Feb; 22(2):103-111. PubMed ID: 31502876
    [No Abstract]   [Full Text] [Related]  

  • 32. Glycemic relapse in a collaborative primary care-based type 2 diabetes management program.
    Wheeler SE; Struebing T; Drury RLC; Caruso L; Teng BQ; Brazauskas R; Hanson RJ; Crotty BH
    J Am Pharm Assoc (2003); 2021; 61(4):476-483.e3. PubMed ID: 33715974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs.
    Luo M; Kong X; Wang H; Zhai X; Cai T; Ding B; Hu Y; Jing T; Su X; Li H; Ma J
    J Diabetes Res; 2020; 2020():6666403. PubMed ID: 33299890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects on Diabetes Medications, Weight and Glycated Hemoglobin Among Adult Patients With Obesity and Type 2 Diabetes: 6-Month Observations From a Full Meal Replacement, Low-Calorie Diet Weight Management Program.
    Shiau JY; So DYF; Dent RR
    Can J Diabetes; 2018 Feb; 42(1):56-60. PubMed ID: 28600119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Switching "Real-World" Diabetes Patients to Degludec from Other Basal Insulins Provides Different Clinical Benefits According to Their Baseline Glycemic Control.
    Tentolouris N; Knudsen ST; Lapolla A; Wolden ML; Haldrup S; Schultes B
    Adv Ther; 2019 May; 36(5):1201-1210. PubMed ID: 30879256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycated albumin (GA) is more advantageous than hemoglobin A1c for evaluating the efficacy of sitagliptin in achieving glycemic control in patients with type 2 diabetes.
    Shima K; Komatsu M; Noma Y; Miya K
    Intern Med; 2014; 53(8):829-35. PubMed ID: 24739602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Randomized Pilot Study of the Effect of Trelagliptin and Alogliptin on Glycemic Variability in Patients with Type 2 Diabetes.
    Nishimura R; Osonoi T; Koike Y; Miyata K; Shimasaki Y
    Adv Ther; 2019 Nov; 36(11):3096-3109. PubMed ID: 31562608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus.
    Kovatchev B; Umpierrez G; DiGenio A; Zhou R; Inzucchi SE
    J Diabetes Sci Technol; 2015 Jun; 9(6):1227-35. PubMed ID: 26078255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Escaping the Hemoglobin A1c-Centric World in Evaluating Diabetes Mellitus Interventions.
    Vigersky RA
    J Diabetes Sci Technol; 2015 Feb; 9(5):1148-51. PubMed ID: 25697718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of glycemic control on the Diabetes Complications Severity Index score and development of complications in people with newly diagnosed type 2 diabetes.
    Pantalone KM; Misra-Hebert AD; Hobbs TM; Wells BJ; Kong SX; Chagin K; Dey T; Milinovich A; Weng W; Bauman JM; Burguera B; Zimmerman RS; Kattan MW
    J Diabetes; 2018 Mar; 10(3):192-199. PubMed ID: 28976724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.